Avantor (AVTR) Total Current Liabilities (2018 - 2026)
Avantor (AVTR) recorded quarterly Total Current Liabilities of $1.4 billion in Q1 2026, down 0.84% quarter-over-quarter from $1.4 billion in Q4 2025, and down 32.79% on a YoY basis from $2.0 billion in Q1 2025.
Avantor (AVTR) Total Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 32.79% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 32.79% YoY), while the FY2025 annual figure was $1.4 billion, down 31.31% from the prior year.
- Total Current Liabilities was $1.4 billion for Q1 2026 at Avantor, down from $1.4 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $2.6 billion in Q2 2025 to a low of $1.4 billion in Q1 2026.
- Historically, Total Current Liabilities has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2023.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities surged 75.86% in 2025, then slumped 32.79% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $1.7 billion in 2022, then dropped by 10.76% to $1.5 billion in 2023, then surged by 35.61% to $2.0 billion in 2024, then plunged by 31.31% to $1.4 billion in 2025, then decreased by 0.84% to $1.4 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Avantor | 6.47 Bn | 6.19 Bn | 500.70 Mn | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.38 Bn |
| Sep 30, 2025 | 1.52 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.03 Bn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.44 Bn |
| Dec 31, 2023 | 1.48 Bn |
| Sep 30, 2023 | 1.49 Bn |
| Jun 30, 2023 | 1.55 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.45 Bn |
| Sep 30, 2021 | 1.32 Bn |
| Jun 30, 2021 | 1.38 Bn |